FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). |
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
HARVEST HEALTH & RECREATION INC. [ HRVSF ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
3. Date of Earliest Transaction
(Month/Day/Year) 10/01/2021 | ||||||||||||||||||||||||||
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price |
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Options | $7.04(1) | 10/01/2021 | D | 240,000 | (2) | (2) | Subordinate Voting Shares | 240,000 | (2) | 0 | D | ||||
Stock Options | $4.05(1) | 10/01/2021 | D | 120,000 | (3) | (3) | Subordinate Voting Shares | 120,000 | (3) | 0 | D | ||||
Stock Options | $1.48(1) | 10/01/2021 | D | 140,000 | (4) | (4) | Subordinate Voting Shares | 140,000 | (4) | 0 | D | ||||
Stock Options | $2.75(1) | 10/01/2021 | D | 200,000 | (5) | (5) | Subordinate Voting Shares | 200,000 | (5) | 0 | D |
Explanation of Responses: |
1. Exercise price is denominated and reported in Canadian dollars. |
2. The stock options were granted on September 10, 2019 and vest in four equal annual installments beginning on September 10, 2020. Adjusted pursuant to the Arrangement Agreement, dated as of May 10, 2021 (the "Arrangement Agreement"), between Harvest Health and Recreation Inc. and Trulieve Cannabis Corp. ("Trulieve"), resulting in an option to receive 28,080 subordinate voting shares of Trulieve with an exercise price of CAD$60.18 per share. |
3. The stock options were granted on February 3, 2020 and vest in four equal annual installments beginning on September 10, 2020. Adjusted pursuant to the Arrangement Agreement resulting in an option to receive 14,040 subordinate voting shares of Trulieve with an exercise price of CAD$34.62 per share. |
4. The stock options were granted on July 14, 2020 and vest in four equal annual installments beginning on July 14, 2021. Adjusted pursuant to the Arrangement Agreement resulting in an option to receive 16,380 subordinate voting shares of Trulieve with an exercise price of CAD$12.65 per share. |
5. The stock options were granted on December 31, 2020 and vest in two equal annual installments beginning on January 1, 2021. Adjusted pursuant to the Arrangement Agreement resulting in an option to receive 23.400 subordinate voting shares of Trulieve with an exercise price of CAD$23.51 per share. |
/s/ Allison McBride, Attorney-in-fact | 10/05/2021 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |